Decode Shares Rise on Prostate Cancer Findings

Shares of Decode Genetics stock were up nearly 11 percent in trading today following Decode researchers' identification of new prostate cancer risk variants.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.